N@N

Clinical Data, Inc. to Present at J.P. Morgan Healthcare Conference

^{Published on 2010-01-06 21:00:19 - Market Wire}
 

NEWTON, Mass.--([ BUSINESS WIRE ])--[ Clinical Data, Inc. ] (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the 28^th Annual J.P. Morgan Healthcare Conference. Clinical Data's presentation will take place at 8:30 a.m. PST on Thursday, January 14, 2010 at The Westin St. Francis hotel, San Francisco, CA.

A live audio and archived webcast of the presentation will be accessible through Clinical Data's website at [ www.clda.com ].

About Clinical Data, Inc.

Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for [ central nervous system disorders ] and [ cardiovascular diseases ], to be followed by promising drug candidates in other major therapeutic areas. Clinical Data is also combining its drug development and biomarker expertise to develop products with enhanced efficacy and tolerability to improve patient health and reduce costs. To learn more, please visit the Company's website at [ www.clda.com ].